Search clinical trials for: Adjuvant nivolumab IV nivolumab and ipililumab intracavitary
Total 1772 results
-
Robert L. Ferris, MD, PhDBristol-Myers SquibbActive, not recruitingOropharynx Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and NeckUnited States
-
Daiichi Sankyo, Inc.Bristol-Myers SquibbTerminatedColorectal NeoplasmUnited States
-
Xijing HospitalRecruitingGastric Cancer | Chemotherapeutic Toxicity | Immune-related Adverse EventChina
-
The Netherlands Cancer InstituteRecruitingCutaneous Squamous Cell CarcinomaNetherlands
-
Bradley A. McGregor, MDBristol-Myers Squibb; ExelixisRecruitingRenal Cell Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Unclassified Renal Cell Carcinoma | Collecting Duct Renal Cell Carcinoma | Translocation Renal Cell Carcinoma | Unresectable Advanced Renal Cell Carcinoma | Metastatic Ncc Renal Cell CarcinomaUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedBroad Solid TumorUnited States, Argentina, Australia, Canada, Chile, Japan, Romania, Singapore
-
Vastra Gotaland RegionBristol-Myers SquibbActive, not recruitingLiver Metastases | Uveal MelanomaSweden
-
TriSalus Life Sciences, Inc.Active, not recruitingHepatocellular Carcinoma | Intrahepatic CholangiocarcinomaUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
Mayo ClinicActive, not recruitingMetastatic Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
Jason J. Luke, MDBristol-Myers Squibb; Agios Pharmaceuticals, Inc.CompletedGlioma | Advanced Solid Tumor | IDH1 MutationUnited States
-
Gruppo Oncologico del Nord-OvestCompletedSquamous Cell Carcinoma of Head and NeckItaly
-
Bristol-Myers SquibbRecruitingClear Cell Renal Cell CarcinomaRussian Federation, New Zealand, United States, Finland, France, Ireland, Italy, Turkey, Poland, Argentina, Brazil, Chile, Czechia, Mexico, Portugal, Romania, Spain
-
Memorial Sloan Kettering Cancer CenterRecruitingMelanoma | Melanoma Stage IIIUnited States
-
University of Texas Southwestern Medical CenterWithdrawnMelanoma | Metastatic MelanomaUnited States
-
Chinese PLA General HospitalNot yet recruitingGastric Cancer | Chemotherapy Effect
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Australia, Belgium, Italy, Poland, Spain, United Kingdom
-
Bristol-Myers SquibbWithdrawnMelanoma | Urothelial CarcinomaGermany, Spain
-
Presage BiosciencesBristol-Myers Squibb; CelgeneTerminated
-
Taiho Oncology, Inc.CompletedRefractory Metastatic Colorectal CancerUnited States
-
Celleron Therapeutics Ltd.UnknownColorectal Neoplasms MalignantUnited Kingdom
-
Bristol-Myers SquibbRecruiting
-
Bispebjerg HospitalUnknownImmune Response | Immunotherapy | BCC - Basal Cell Carcinoma | Ablative Fractionated LaserDenmark
-
National Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
ArdigenNational Center for Research and Development, Poland; The Institute of Bioorganic...UnknownMelanoma | Healthy Volunteers | Metagenome | Immunotherapy | MicrobiomePoland
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
National Cancer Institute (NCI)CompletedAcute Adult T-Cell Leukemia/Lymphoma | Adult T-Cell Leukemia/Lymphoma | Chronic Adult T-Cell Leukemia/Lymphoma | HTLV-1 Infection | Lymphomatous Adult T-Cell Leukemia/Lymphoma | Smoldering Adult T-Cell Leukemia/LymphomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
Ralph G ZinnerBristol-Myers SquibbRecruitingLung Cancer, Nonsmall Cell | Lung Cancer Stage IIIUnited States
-
Providence Health & ServicesBristol-Myers Squibb; ExelixisActive, not recruitingRefractory Cutaneous MelanomaUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI)Active, not recruitingMajor Salivary Gland Carcinoma | Recurrent Salivary Gland Carcinoma | Stage IVA Major Salivary Gland Carcinoma | Stage IVB Major Salivary Gland Carcinoma | Stage IVC Major Salivary Gland Carcinoma | Minor Salivary Gland Carcinoma | Stage IV Major Salivary Gland CarcinomaUnited States
-
University of MelbourneThe AlfredRecruitingHIV I InfectionSingapore, Australia
-
Asan Medical CenterRecruitingHepatocellular Carcinoma | Biliary Tract CancerKorea, Republic of
-
Fujian Medical UniversityActive, not recruitingLocally Advanced Gastric CancerChina
-
BayerBristol-Myers SquibbCompleted
-
Seoul National University HospitalCompletedRecurrent or Metastatic Nasopharyngeal CarcinomKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; BayerActive, not recruitingEsophagogastric Cancer | HER2-NegativeUnited States
-
Bristol-Myers SquibbRecruitingMelanomaUnited States, Canada, Switzerland, Italy, Spain, Australia, France, Belgium, Finland, Israel, Germany, Sweden, Argentina, Brazil, Colombia, Mexico, Chile, United Kingdom, Austria, Poland, Czechia, Norway
-
Bristol-Myers SquibbNo longer available
-
Fujian Cancer HospitalWithdrawnGastric Adenocarcinoma | Esophagus Adenocarcinoma | Esophagogastric Junction AdenocarcinomaChina
-
St. Petersburg State Pavlov Medical UniversityCompletedHodgkin LymphomaRussian Federation
-
Sarcoma Oncology Research Center, LLCBristol-Myers SquibbRecruitingSAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue SarcomaAdvanced Soft Tissue Sarcoma | Metastatic Soft Tissue SarcomaUnited States
-
Bristol-Myers SquibbActive, not recruitingHepatocellular CarcinomaGermany, Romania, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, France, Hong Kong, Italy, Japan, Korea, Republic of, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Switzerland and more
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Sumitomo Pharma America, Inc.Completed
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedVarious Advanced CancerUnited States, Belgium, France, Germany, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
-
Robert R. McWilliams, MDBristol-Myers Squibb; Hoosier Cancer Research NetworkActive, not recruiting
-
ImmuneSensor Therapeutics Inc.RecruitingOligometastatic DiseaseUnited States